Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenoldopam mesylate vs sodium nitroprusside in hypertensive emergencies
CTR20130438Phase 2Completed
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Mar 2014
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenoldopam in hypertensive emergency, sponsored by Yangtze River Pharmaceutical Group. Started Mar 2014; status: completed.
02
Drugs
fenoldopam
03
Conditions
hypertensive emergency
Beyond the preview
Go deeper on CTR20130438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130438.